Lipella Pharmaceuticals Inc. (LIPO) income statement
LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2025, quý kết thúc ngày Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 6/30
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.27KP/E –Yield –
Lipella Pharmaceuticals Inc. income statement
Ratios
Latest available, balances at Sep 30, 2025
Profitability, TTM
- Gross margin
- –
- Operating margin
- -1387.9%
- Net margin
- -1367.4%
- Return on equity, FY2024
- -198.1%
Financial strength
- Current ratio
- 3.24
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 288.9%
Valuation
- P/E ratio
- –
- Price to sales
- 0.01
- Price to book
- 0.00
- Dividend yield
- –
See a number that looks wrong?